Patents Assigned to Biopharmed
  • Patent number: 8614230
    Abstract: The invention relates to compounds of the aminated hydroxyquinoline type capable of preventing the migration of metastases or tumoral cells. Such compounds are useful for treating cancers.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: December 24, 2013
    Assignee: Biopharmed
    Inventors: Jean-Louis Kraus, Olivier Blin, Frederic Champavere
  • Publication number: 20130102630
    Abstract: The invention relates to compounds of the aminated hydroxyquinoline type capable of preventing the migration of metastases or tumoral cells. Such compounds are useful for treating cancers.
    Type: Application
    Filed: November 30, 2012
    Publication date: April 25, 2013
    Applicant: BIOPHARMED
    Inventor: BIOPHARMED
  • Patent number: 8324243
    Abstract: The invention relates to compounds of the aminated hydroxyquinoline type capable of preventing the migration of metastases or tumoral cells. Such compounds are useful for treating cancers.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: December 4, 2012
    Assignee: Biopharmed
    Inventors: Jean-Louis Kraus, Olivier Blin, Frederic Champavere
  • Publication number: 20110251238
    Abstract: Method for treating or preventing a PPAR-responsive condition in a subject, comprising administering to the subject a PPAR agonist that comprises a 8-hydroxyquinoline-methylene-N- group in an amount effective to activate a PPAR polypeptide.
    Type: Application
    Filed: December 23, 2009
    Publication date: October 13, 2011
    Applicant: BIOPHARMED
    Inventors: Jean-Louis Kraus, Olivier Blin, Frédéric Champavere
  • Publication number: 20100120856
    Abstract: The invention relates to compounds of the animated hydroxyquinoline type capable of preventing the migration of metastases or tumoral cells. Such compounds are useful for treating cancers.
    Type: Application
    Filed: March 25, 2008
    Publication date: May 13, 2010
    Applicant: BIOPHARMED
    Inventors: Jean-Louis Kraus, Olivier Blin, Frederic Champavere